U.S. Markets open in 9 hrs 2 mins

Cellect Biotechnology (APOP) Jumps: Stock Moves 10.5% Higher

Zacks Equity Research

Cellect Biotechnology Ltd. APOP was a big mover last session, as the company saw its shares rise over 10% on the day. The move came after the company announced that it has received a formal notice of Intention to Grant for a patent covering a key method of treatment from the European Patent Office. This also led to far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $5.94 to $10.90 in the past one-month time frame.

None of the estimates for this stock were revised in the last 30 days and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Currently, Cellect Biotechnology carries a Zacks Rank #3 (Hold).

Cellect Biotechnology Ltd. Price


Cellect Biotechnology Ltd. Price | Cellect Biotechnology Ltd. Quote

A better-ranked stock in the same industry is Anthera Pharmaceuticals, Inc. ANTH, sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is APOP going up? Or down? Predict to see what others think: Up or Down

Zacks’ Best Private Investment Ideas

While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public. Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Click here for Zacks' private trades >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Anthera Pharmaceuticals, Inc. (ANTH): Free Stock Analysis Report
Cellect Biotechnology Ltd. (APOP): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research